| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Service dEndocrinologie et Maladies Métaboliques, CHU Rangueil (P.C., A.B.), 31054 Toulouse, France; Biologia Generale e Genetica Medica, Università di Pavia (S.I., G.C.), 27100 Pavia, Italy; Laboratoire de Biochimie, CHU La Grave (M.P.), and Service de Pédiatrie et Génétique Médicale, CHU Purpan (P.R.), Toulouse, France
Address all correspondence and requests for reprints to: Philippe Caron, M.D., Service dEndocrinologie, CHU Rangueil, 1 avenue J. Poulhes, 31054 Toulouse Cedex, France. E-mail: caron.p{at}chu-toulouse.fr
We have studied a 20-yr-old male patient with adrenal hypoplasia
congenita and hypogonadotropic hypogonadism (HH) due to a C to A
transversion at nucleotide 825 in the DAX-1 gene,
resulting in a stop codon at position 197. The same mutation was
detected in his affected first cousin (adrenal hypoplasia congenita and
HH) and in a heterozygous state in their carrier mothers. The patient
had had acute adrenal insufficiency at the age of 2 yr and 6 months,
bilateral cryptorchidism corrected surgically at the age of 12 yr, and
failure of spontaneous puberty. Plasma testostereone (T) was
undetectable (<0.30 nmol/L), gonadotropin levels were low (LH, <0.4
IU/L; FSH, 1.5 IU/L) and not stimulated after iv injection of 100 µg
GnRH. The endogenous LH secretory pattern was apulsatile, whereas free
-subunit (FAS) levels depicted erratic pulses, suggesting an
incomplete deficiency of hypothalamic GnRH secretion. During iv
pulsatile GnRH administration (10 µg/pulse every 90 min for 40
h), each GnRH pulse induced a LH response of low amplitude (0.54
± 0.05 UI/L), whereas mean LH (0.45 ± 0.01 IU/L) and FAS
(63 ± 8 mU/L) levels remained low. Amplitude of LH peaks
(0.83 ± 0.09 IU/L), mean LH (0.53 ± 0.02 IU/L), and FAS
(161 ± 18 mU/L) levels increased (P < 0.01),
whereas the T concentration remained low (0.75 nmol/L) when the
pulsatile GnRH regimen was raised to 20 µg/pulse for a 40-h period,
suggesting a partial pituitary resistance to GnRH. Thereafter, plasma T
levels remained in prepubertal value after three daily im injections of
5000 IU hCG (3.6 nmol/L) and after 1-yr treatment with weekly im
injections of 1500 IU hCG (1.2 nmol/L), implying Leydig cell resistance
to hCG. The patient had a growth spurt, bone maturation, progression of
genital and pubic hair stages, and normalization of plasma T level
(15.8 nmol/L) after a 12-month treatment with twice weekly injections
of hCG and human menopausal gonadotropin (75 IU International Reference
Preparation 2) preparations, suggesting that, in presence of FSH, a
Sertoli cell-secreted factor stimulated Leydig cell production of T. In
conclusion, we report a novel mutation in the DAX-1 gene
in patients with AHC and HH. Our results suggest that the hypogonadism
is due to a combined hypothalamic-pituitary-gonadal defect and imply
that the DAX-1 gene may play a critical role in human
testicular function.
This article has been cited by other articles:
![]() |
C Russo, E J Davis, P R Betts, and J H Davies The importance of re-evaluation, re-investigation and follow-up of adrenal insufficiency Arch. Dis. Child. Ed. Pract., August 1, 2007; 92(4): ep109 - ep113. [Full Text] [PDF] |
||||
![]() |
J. J. Meeks, T. A. Russell, B. Jeffs, I. Huhtaniemi, J. Weiss, and J. L. Jameson Leydig Cell-Specific Expression of DAX1 Improves Fertility of the Dax1-Deficient Mouse Biol Reprod, July 1, 2003; 69(1): 154 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brown, G. A. Scobie, J. Townsend, R. A. L. Bayne, J. R. Seckl, P. T. K. Saunders, and R. A. Anderson Identification of a Novel Missense Mutation That Is as Damaging to DAX-1 Repressor Function as a Nonsense Mutation J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1341 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Tremblay and R. S. Viger Nuclear Receptor Dax-1 Represses the Transcriptional Cooperation Between GATA-4 and SF-1 in Sertoli Cells Biol Reprod, April 1, 2001; 64(4): 1191 - 1199. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |